Skip to main content

Table 6 Comparison of RECIST 1.1 and PERCIST response assessment

From: The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer

PECIST 1.1

PERCIST

CMR

PMR

SMD

PMD

Total

CR

0

0

0

0

0

PR

0

30

5

0

35

SD

0

7

6

2

15

PD

0

0

1

0

1

Total

0

37

12

2

51

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us